2016
Role of substance P in the cardiovascular system
MISTROVA, Eliska; Peter KRUŽLIAK a Magdalena DVORAKOVA CHOTTOVAZákladní údaje
Originální název
Role of substance P in the cardiovascular system
Autoři
MISTROVA, Eliska; Peter KRUŽLIAK a Magdalena DVORAKOVA CHOTTOVA
Vydání
NEUROPEPTIDES, EDINBURGH, CHURCHILL LIVINGSTONE, 2016, 0143-4179
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30202 Endocrinology and metabolism
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.486
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/16:00100473
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Substance P; NK1 receptor; Cardiovascular regulation; Antagonist
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 11. 5. 2018 15:16, Soňa Böhmová
Anotace
V originále
This article provides an overview of the structure and function of substance P signalling system and its involvement in the cardiovascular regulation. Substance P is an undecapeptide originating from TAC1 gen and belonging to the tachykinin family. The biological actions of substance P are mainly mediated through neurokinin receptor 1 since substance P is the ligand with the highest affinity to neurokinin receptor 1. Substance P is widely distributed within the central and peripheral nervous systems as well as in the cardiovascular system. Substance P is involved in the regulation of heart frequency, blood pressure and in the stretching of vessels. Substance P plays an important role in ischemia and reperfusion and cardiovascular response to stress. Additionally, it has been also implicated in angiogenesis, pain transmission and inflammation. The substance P/neurokinin receptor 1 receptor system is involved in the molecular bases of many human pathological processes. Antagonists of neurokinin receptor 1 receptor could provide clinical solutions for a variety of diseases. Neurokinin receptor 1 antagonists are already used in the prevention of chemotherapy induced nausea and vomiting. (C) 2015 Elsevier Ltd. All rights reserved.